Concepedia

David R. Jones

DR

Statistics

Publications

30

Citations

2.8K

H-Index

22

Active since

1973

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Indiana University Health

Indiana University Bloomington

Sidney & Lois Eskenazi Hospital

David R. Jones is an author at Indiana University – Purdue University Indianapolis specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1973–2022

30

Publications

30

The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity

Bryan A. Ward, J. Christopher Gorski, David R. Jones et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 594 citations

, , +17

Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7

J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell et al. · Drug Metabolism and Disposition · 2002 · 468 citations

, , +17

An In Vitro Model for Predicting In Vivo Inhibition of Cytochrome P450 3A4 by Metabolic Intermediate Complex Formation

David R. Jones, Stephen D. Hall · Drug Metabolism and Disposition · 2000 · 294 citations

, , +17

Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis.

Miguel Vicente‐Manzanares, David R. Jones, David Sancho et al. · PubMed · 1999 · 151 citations

, , +17

Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival

Jason G. Kettle, Husam Alwan, Michał Biśta et al. · Journal of Medicinal Chemistry · 2016 · 136 citations · Full text

, , +6

1–5 of 30